EULAR® 2024 Insights
EULAR® 2024 Insights: Glucocorticoid Reduction and Withdrawal in Patients With Systemic Lupus Erythematosus Receiving Long-term Anifrolumab Treatment
By
EULAR® 2024 Insights
FEATURING
Richard Furie
By
EULAR® 2024 Insights
FEATURING
Richard Furie
Comments 0
Login to view comments.
Click here to Login
